Low estrogen receptor (ER) positive breast cancer and neoadjuvant systemic therapy (NAT): Is response similar to ER plus or to ER- disease?

被引：1
|
作者：
Landmann, Alessandra
Farrugia, Daniel J.
Diego, Emilia
Soran, Atilla
Johnson, Ronald
Bonaventura, Marguerite
Dabbs, David J.
Clark, Beth
Brufsky, Adam
Davidson, Nancy E.
Lembersky, Barry C.
Jankowitz, Rachel Catherine
Puhalla, Shannon
Ahrendt, Gretchen M.
McAuliffe, Priscilla F.
Bhargava, Rohit
机构：
[1] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA
[2] Univ Pittsburgh, Pittsburgh, PA USA
[3] UPMC, Magee Womens Hosp, Pittsburgh, PA USA
[4] Magee Womens Hosp, Pittsburgh, PA USA
[5] Magee Womens Hosp, Dept Path, Pittsburgh, PA USA
[6] NRG Oncol NSABP, Pittsburgh, PA USA
[7] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.580
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
580
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Polymorphisms in ER-α gene interact with estrogen receptor status in breast cancer survival
    Boyapati, SM
    Shu, XO
    Ruan, ZM
    Cail, Q
    Smith, JR
    Wen, WQ
    Gao, YT
    Zheng, W
    CLINICAL CANCER RESEARCH, 2005, 11 (03) : 1093 - 1098
  • [32] PARP inhibition effects on endocrine therapy and resistance in estrogen receptor positive (ER plus ) breast cancer models
    Nardone, Agostina
    Goldstein, Amit
    Shea, Martin J.
    Mithchell, Tamika
    Fu, Xiaoyong
    De Angelis, Carmine
    Hu, Huizhong
    Xu, Xiaowei
    Rajendran, Mahitha
    O'Connor, Mark
    Locker, Gershon
    Hilsenbeck, Susan
    Osborne, Kent
    Schiff, Rachel
    CANCER RESEARCH, 2015, 75
  • [33] Expression of estrogen receptor (ER) βcx protein in ERα-positive breast cancer:: Specific correlation with progesterone receptor
    Saji, S
    Omoto, Y
    Shimizu, C
    Warner, M
    Hayashi, Y
    Horiguchi, S
    Watanabe, T
    Hayashi, S
    Gustafsson, JÅ
    Toi, M
    CANCER RESEARCH, 2002, 62 (17) : 4849 - 4853
  • [34] Low phosphorylation of estrogen receptor a (ERα) serine 118 and high phosphorylation of ERα serine 167 improve survival in ER-positive breast cancer
    Yamashita, Hiroko
    Nishio, Mariko
    Toyama, Tatsuya
    Sugiura, Hiroshi
    Kondo, Naoto
    Kobayashi, Shunzo
    Fujii, Yoshitaka
    Iwase, Hirotaka
    ENDOCRINE-RELATED CANCER, 2008, 15 (03) : 755 - 763
  • [35] Expression levels of estrogen receptor (ER) gene and three ER-related genes in metastatic ER-positive breast cancer compared with response to endocrine therapy.
    Lai, S
    Valero, V
    Booster, D
    Fiterman, DJ
    Pusztai, L
    Symmans, WF
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S60 - S60
  • [36] ANALYSIS OF DIFFERENT SYMPTOMS IN ESTROGEN RECEPT OR POSITIVE (ER+) OR NEGATIVE (ER-) BREAST CARCINOMAS (BC)
    COCCONI, G
    CECI, G
    BOZZETTI, C
    CANALI, F
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 340 - 340
  • [37] Effects of bazedoxifene and lapatinib in the prevention of estrogen receptor positive (ER+) and negative (ER-) mammary cancers
    Grubbs, Clinton J.
    Mohammed, Altaf
    Sei, Shizuko
    Shoemaker, Robert H.
    CANCER RESEARCH, 2019, 79 (13)
  • [38] Acquired FGF and FGFR alterations confer resistance to estrogen receptor (ER) targeted therapy in metastatic ER plus breast cancer
    Mao, Pingping
    Cohen, Ofir
    Kowalski, Kailey
    Kusiel, Justin
    Buendia, Jorge
    Exman, Pedro
    Wander, Seth A.
    Waks, Adrienne G.
    Winer, Eric P.
    Lin, Nancy U.
    Wagle, Nikhil
    CANCER RESEARCH, 2019, 79 (13)
  • [39] Estrogen receptor (ER) and NFkB activity determines cancer stem cell properties in ER positive breast cancer
    Semina, Svetlana E.
    Kastrati, Irida
    Cruz, Luis Alejo
    McCray, Tara
    Maienschein-Cline, Mark
    Alarid, Elaine T.
    Frasor, Jonna
    CANCER RESEARCH, 2021, 81 (04)
  • [40] Estrogen receptor (ER) was regulated by RNPC1 stabilizing mRNA in ER positive breast cancer
    Shi, Liang
    Xia, Tian-Song
    Wei, Xiao-Long
    Zhou, Wenbin
    Xue, Jinqiu
    Cheng, Lin
    Lou, Peipei
    Li, Chunlian
    Wang, Ying
    Wei, Ji-Fu
    Ding, Qiang
    ONCOTARGET, 2015, 6 (14) : 12264 - 12278
12345